C
Charles River Laboratories International, Inc. (CRL)
NYQ – Real Time Price. Currency in USD
159.16
-5.97 (-3.62%)
At close: Mar 27, 2026, 4:00 PM EDT
158.00
-1.16 (-0.73%)
After-hours: Mar 27, 2026, 6:14 PM EDT

NYQ – Real Time Price. Currency in USD
159.16
-5.97 (-3.62%)
At close: Mar 27, 2026, 4:00 PM EDT
158.00
-1.16 (-0.73%)
After-hours: Mar 27, 2026, 6:14 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.29 | 2.46 | 7.0 | |
| Quick ratio | 1.02 | 2.06 | 7.0 | |
| Debt to Equity | 0.83 | -0.13 | 6.0 | |
| Debt to Assets | 0.37 | 1.87 | 6.0 | |
| Interest coverage | 5.01 | 4.31 | 10 | |
| Weighted average score | 7.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 3.98B | 4.13B | 4.05B | 4.02B | 4.02B |
| Gross Profit | 1.32B | 1.39B | 1.27B | 1.23B | 1.23B |
| Operating Income | 653M | 661M | 567M | 516M | 501M |
| Net Income | 486M | 475M | 10M | -144M | -144M |
| EBITDA | 956M | 975M | 929M | 919M | 904M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -0.34 | -17.41 | 1.0 |
| Next quarter | -2.04 | -7.72 | 1.0 |
| Current year | -0.01 | 7.67 | 3.5 |
| Next year | 3.57 | 8.77 | 5.0 |
| Weighted average score | 2.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -1.05 | -608.16 | -1.64 | -67.13 | 1.0 |
| Y/Y | -0.82 | -28.2 | -10.14 | -30.05 | 1.0 |
| 3y average | 0.37 | -533.97 | -2.55 | 21.52 | 3.5 |
| 5y average | 6.9 | -314.04 | 5.4 | 12 | 4.5 |
| Weighted average score | 2.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Medium | 7.0 |
| Intangible assets | Medium | 6.0 |
| Switching costs | Wide | 8.0 |
| Network effect | Medium | 6.0 |
| Economies of scale | Medium | 7.0 |
| Weighted average score | 6.8 | |
Total debt $2.6B significantly exceeds cash reserves ($214.4M), raising financial stability concerns
Total current assets $1.4B exceed Total current liabilities $1.1B, highlighting excellent liquidity
Debt-to-equity ratio (0.8) is near the industry average, reflecting balanced leverage
Interest coverage ratio (5x) indicates the company easily manages its debt payments
The company generates positive free cash flow $58.6M, supporting its financial health